SCHEMBL9107847

SCHEMBL9107847

COC(=O)C(CC1CCCC1)N1C(=O)C(=O)c2ccc(C)cc21

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 13/20 0.40
ALDH1A1 P00352 2/20 0.37
USP19 O94966 1/20 0.37
REN P00797 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9105979 0.91 ALDH1A1 (0.44) GCKALDH1A1
SCHEMBL9107265 0.89 GCK (0.40) GCKALDH1A1USP19
SCHEMBL9106688 0.88 GCK (0.36) GCKALDH1A1USP19REN
SCHEMBL9108781 0.88 F11 (0.38) GCKREN
SCHEMBL9105799 0.88 GCK (0.36) GCKALDH1A1USP19REN
SCHEMBL9107551 0.86 RAB9A (0.36) GCKALDH1A1USP19REN
SCHEMBL9109747 0.85 ALDH1A1 (0.46) GCKALDH1A1USP19REN
SCHEMBL9105493 0.82 PARK7 (0.39) GCKALDH1A1
SCHEMBL9102207 0.82 F11 (0.40) GCKALDH1A1
SCHEMBL9107290 0.82 CUL4A (0.43) GCKALDH1A1USP19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-5389680-A Insecticides, nematocides, miticides MONSANTO COMPANY (US) 1995-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885ALDH1A1 646/4885USP19 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.